Label: CURITHYS- sodium hyaluronate patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated December 1, 2021

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Sodium hyaluronate

  • INACTIVE INGREDIENT

    Niacinamide
    Salicylic Acid
    Sh-Oligopepide-1
    Sh-Polypepide-1
    TetraPeptide-44
    Centella Asiatica Extract
    Tranexamic acid
    Camellia Japonica Flower Extract

  • PURPOSE

    Micro-pyramid stimulates the skin and gives moisture and nutrition to sensitive skin.

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    Remove the protective film from the patch.

    Attach it vertically to the desired site.

    Re-press on thea ttached patch every few minutes..

    Remove the patch after attaching for more than 1 hour.

  • WARNINGS

    Use it for your own use only.

    For external use only.

    Discontinue use if adverse reaction occurs.

    Contact a physician if symptoms persist.

    Store at room temperature

    .Do not reuse it as a disposable product.

    Please use it immediately after opening.

  • DOSAGE & ADMINISTRATION

    for topical use only

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    CURITHYS 
    sodium hyaluronate patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72945-0002
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM94.39 mg  in 100 mg
    Inactive Ingredients
    Ingredient NameStrength
    NIACINAMIDE (UNII: 25X51I8RD4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72945-0002-26 in 1 POUCH07/21/2019
    1NDC:72945-0002-15 mg in 1 PATCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other07/21/2019
    Labeler - J World (690082781)
    Registrant - J World (690082781)
    Establishment
    NameAddressID/FEIBusiness Operations
    J World690082781label(72945-0002) , manufacture(72945-0002)